MHRA Class 4 Medicines Notification, Chemidex Pharma Ltd, Various Products, EL(25)A/21

Chemidex Pharma Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in their topical steroid products does not contain all the required safety information. Cartons for the products/batches listed are missing side effect information related to Visual Disturbances.

Full information can be found in the notification published on the MHRA website at the link below:

https://www.gov.uk/drug-device-alerts/class-4-medicines-notification-chemidex-pharma-ltd-various-products-el-25-a-slash-21?cachebust=1747130404